
### [MONDO:0000835](http://purl.obolibrary.org/obo/MONDO_0000835)
**Label:** ischemic bone disease

**Subclasses:** [MONDO:0016320](http://purl.obolibrary.org/obo/MONDO_0016320) (rare hereditary thrombophilia), [MONDO:0018379](http://purl.obolibrary.org/obo/MONDO_0018379) (primary avascular necrosis), [MONDO:0018377](http://purl.obolibrary.org/obo/MONDO_0018377) (rare hereditary disease with avascular necrosis), [MONDO:0018374](http://purl.obolibrary.org/obo/MONDO_0018374) (secondary avascular necrosis), [MONDO:0019144](http://purl.obolibrary.org/obo/MONDO_0019144) (hereditary thrombophilia due to congenital protein S deficiency), [MONDO:0019145](http://purl.obolibrary.org/obo/MONDO_0019145) (hereditary thrombophilia due to congenital protein c deficiency), [MONDO:0018373](http://purl.obolibrary.org/obo/MONDO_0018373) (avascular necrosis), [MONDO:0018381](http://purl.obolibrary.org/obo/MONDO_0018381) (osteochondrosis), [MONDO:0005380](http://purl.obolibrary.org/obo/MONDO_0005380) (osteonecrosis), 

**Corr. equiv. classes:** [Orphanet:399185](http://www.orpha.net/ORDO/Orphanet_399185), [Orphanet:399164](http://www.orpha.net/ORDO/Orphanet_399164), [Orphanet:399158](http://www.orpha.net/ORDO/Orphanet_399158), [Orphanet:217454](http://www.orpha.net/ORDO/Orphanet_217454), [Orphanet:399169](http://www.orpha.net/ORDO/Orphanet_399169), [OMIM:614514](http://purl.obolibrary.org/obo/OMIM_614514), [OMIM:176860](http://purl.obolibrary.org/obo/OMIM_176860), [Orphanet:399302](http://www.orpha.net/ORDO/Orphanet_399302), [OMIM:612336](http://purl.obolibrary.org/obo/OMIM_612336), [OMIM:612304](http://purl.obolibrary.org/obo/OMIM_612304), [Orphanet:745](http://www.orpha.net/ORDO/Orphanet_745), [Orphanet:399319](http://www.orpha.net/ORDO/Orphanet_399319), [Orphanet:743](http://www.orpha.net/ORDO/Orphanet_743), 

**Class expressions from DL-Learner:**

- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and (not ([HP:0004419](http://purl.obolibrary.org/obo/HP_0004419) (Recurrent thrombophlebitis))) 69.23%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) 65.38%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0100724](http://purl.obolibrary.org/obo/HP_0100724) (Hypercoagulability) 65.38%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0030780](http://purl.obolibrary.org/obo/HP_0030780) (Abnormality of the protein C anticoagulant pathway) 65.38%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 65.38%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 65.38%
- [HP:0003256](http://purl.obolibrary.org/obo/HP_0003256) (Abnormality of the coagulation cascade) and [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) 65.38%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0100724](http://purl.obolibrary.org/obo/HP_0100724) (Hypercoagulability) 65.38%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0030875](http://purl.obolibrary.org/obo/HP_0030875) (Abnormality of pulmonary circulation) 65.38%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0030780](http://purl.obolibrary.org/obo/HP_0030780) (Abnormality of the protein C anticoagulant pathway) 65.38%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0030163](http://purl.obolibrary.org/obo/HP_0030163) (Abnormal vascular physiology) 65.38%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 65.38%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0003256](http://purl.obolibrary.org/obo/HP_0003256) (Abnormality of the coagulation cascade) 65.38%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0002795](http://purl.obolibrary.org/obo/HP_0002795) (Functional respiratory abnormality) 65.38%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) 65.38%



### [MONDO:0000835](http://purl.obolibrary.org/obo/MONDO_0000835)
**Label:** ischemic bone disease

**Subclasses:** [MONDO:0016320](http://purl.obolibrary.org/obo/MONDO_0016320) (rare hereditary thrombophilia), [MONDO:0018379](http://purl.obolibrary.org/obo/MONDO_0018379) (primary avascular necrosis), [MONDO:0018377](http://purl.obolibrary.org/obo/MONDO_0018377) (rare hereditary disease with avascular necrosis), [MONDO:0018374](http://purl.obolibrary.org/obo/MONDO_0018374) (secondary avascular necrosis), [MONDO:0019144](http://purl.obolibrary.org/obo/MONDO_0019144) (hereditary thrombophilia due to congenital protein S deficiency), [MONDO:0019145](http://purl.obolibrary.org/obo/MONDO_0019145) (hereditary thrombophilia due to congenital protein c deficiency), [MONDO:0018373](http://purl.obolibrary.org/obo/MONDO_0018373) (avascular necrosis), [MONDO:0018381](http://purl.obolibrary.org/obo/MONDO_0018381) (osteochondrosis), [MONDO:0005380](http://purl.obolibrary.org/obo/MONDO_0005380) (osteonecrosis), 

**Corr. equiv. classes:** [Orphanet:399185](http://www.orpha.net/ORDO/Orphanet_399185), [Orphanet:399164](http://www.orpha.net/ORDO/Orphanet_399164), [Orphanet:399158](http://www.orpha.net/ORDO/Orphanet_399158), [Orphanet:217454](http://www.orpha.net/ORDO/Orphanet_217454), [Orphanet:399169](http://www.orpha.net/ORDO/Orphanet_399169), [OMIM:614514](http://purl.obolibrary.org/obo/OMIM_614514), [OMIM:176860](http://purl.obolibrary.org/obo/OMIM_176860), [Orphanet:399302](http://www.orpha.net/ORDO/Orphanet_399302), [OMIM:612336](http://purl.obolibrary.org/obo/OMIM_612336), [OMIM:612304](http://purl.obolibrary.org/obo/OMIM_612304), [Orphanet:745](http://www.orpha.net/ORDO/Orphanet_745), [Orphanet:399319](http://www.orpha.net/ORDO/Orphanet_399319), [Orphanet:743](http://www.orpha.net/ORDO/Orphanet_743), 

**Class expressions from DL-Learner:**

- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) 65.38%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0100724](http://purl.obolibrary.org/obo/HP_0100724) (Hypercoagulability) 65.38%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0030780](http://purl.obolibrary.org/obo/HP_0030780) (Abnormality of the protein C anticoagulant pathway) 65.38%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 65.38%
- [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 65.38%
- [HP:0003256](http://purl.obolibrary.org/obo/HP_0003256) (Abnormality of the coagulation cascade) and [HP:0004418](http://purl.obolibrary.org/obo/HP_0004418) (Thrombophlebitis) 65.38%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0100724](http://purl.obolibrary.org/obo/HP_0100724) (Hypercoagulability) 65.38%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0030875](http://purl.obolibrary.org/obo/HP_0030875) (Abnormality of pulmonary circulation) 65.38%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0030780](http://purl.obolibrary.org/obo/HP_0030780) (Abnormality of the protein C anticoagulant pathway) 65.38%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0030163](http://purl.obolibrary.org/obo/HP_0030163) (Abnormal vascular physiology) 65.38%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 65.38%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0003256](http://purl.obolibrary.org/obo/HP_0003256) (Abnormality of the coagulation cascade) 65.38%
- [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) and [HP:0002795](http://purl.obolibrary.org/obo/HP_0002795) (Functional respiratory abnormality) 65.38%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) 65.38%
- [HP:0002204](http://purl.obolibrary.org/obo/HP_0002204) (Pulmonary embolism) and [HP:0002638](http://purl.obolibrary.org/obo/HP_0002638) (Superficial thrombophlebitis) 65.38%


